CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES ›› 2017, Vol. 35 ›› Issue (6): 520-526.
• ORGINAL ARTICLE • Previous Articles Next Articles
Zhi-gui XIA1, Ming XU2, Jin-kou ZHAO2, Sheng-jie LAI3, Xiao-nong ZHOU1,*()
Received:
2017-09-18
Online:
2017-12-30
Published:
2018-01-10
Contact:
Xiao-nong ZHOU
E-mail:zhouxn1@chinacdc.cn
Supported by:
CLC Number:
Zhi-gui XIA, Ming XU, Jin-kou ZHAO, Sheng-jie LAI, Xiao-nong ZHOU. An overview on cooperation strength between China and the Global Fund to Fight AIDS, Tuberculosis and Malaria in developing multilateral malaria control projects[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2017, 35(6): 520-526.
Table 1
Countries that exported malaria cases to China in 2011-2014
年均输入 病例数 Average No. of annual imported cases | 来源 国家数 No. of countries | 来源国家名(输入病例数) Names of countries (No. of imported cases) |
---|---|---|
≤ 20 | 38 | 南苏丹South Sudan(15.3)、贝宁Benin(15.0)、南非South Africa(14.0)、马里Mali(13.0)、印度India(12.0)、马拉维Malawi(8.3)、巴布亚新几内亚Papua New Guinea(7.5)、肯尼亚Kenya(6.5)、马达加斯加Madagascar(6.3)、尼日尔Niger(4.5)、布基纳法索Burkina Faso(4.5)、中非共和国Central African Republic(4.3)、利比亚Libya(4.0)、越南Vietnam(2.5)、泰国Thailand(2.5)、塞内加尔Senegal(2.3)、卢旺达Rwanda(2.3)、阿尔及利亚Algeria(2.3)、东帝汶Timor-Leste(1.8)、津巴布韦Zimbabwe(1.5)、埃及Egypt(1.5)、圭亚那Guyana(1.3)、科摩罗Comoros(0.8)、毛里塔尼亚Mauritania(0.8)、布隆迪Burundi(0.8)、孟加拉国Bangladesh(0.8)、马来西亚Malaysia(0.8)、纳米比亚Namibia(0.5)、阿富汗Afghanistan(0.5)、朝鲜Korea(D.P.R)(0.5)、毛里求斯Mauritius(0.3)、巴西Brazil(0.3)、瓜多尔Ecuador(0.3)、马里Somalia(0.3)、所罗门群岛Solomon Islands(0.3)、苏里南Suriname(0.3)、斯里兰卡Sri Lanka(0.3)、文莱Brunei(0.3) |
21~40 | 11 | 莫桑比克Mozambique(40.0)、苏丹Sudan(37.8)、加蓬Gabon(33.0)、老挝Laos(29.8)、赞比亚Zambia(27.0)、坦桑尼亚Tanzania(U.R)(25.0)、乍得Chad(22.0)、巴基斯坦Pakistan(22.0)、乌干达Uganda(21.5)、多哥Togo(21.5)、科特迪瓦Côte d'Ivoire(21.3) |
41~100 | 9 | 喀麦隆Cameroon(80.8)、刚果(布)Congo(75.8)、印尼Indonesia(72.5)、几内亚Guinea(58.0)、埃塞俄比亚Ethiopia(57.5)、利比里亚Liberia(53.8)、柬埔寨Cambodia(50.5)、刚果(金)Congo (D.R)(43.8)、塞拉利昂Sierra Leone(41.0) |
> 100 | 5 | 缅甸Myanmar(752.0)、加纳Ghana(465.5)、安哥拉Angola(287.0)、赤道几内亚Equatorial Guinea(254.3)、尼日利亚Nigeria(246.8) |
合计Total | 63 |
Table 2
The Global Fund malaria allocation during 2017-2019
全球基金分区a Global Fund Region | 不同经费占比的国家/区域个数和名称 No. and name of countries by % of allocation | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
< 1.0% | 1.0%-1.9% | 2.0%-4.5% | 5.0%-6.0% | > 9.0% | 小计Subtotal | |||||||||
国家数No. of countries | 国家名 Names of countries | 国家数 No. of countries | 国家名Names of countries | 国家数 No. of countries | 国家名Names of countries | 国家数 No. of countries | 国家名Names of countries | 国家数 No. of countries | 国家名Names of countries | 国家数 No. of countries | 经费占比/%Funds proportion/% | |||
高影响非洲 HI Africa | 1 | 桑给巴尔Zanzibar | 2 | 肯尼亚Kenya、津巴布韦Zimbabwe | 6 | 加纳Ghana、科特迪瓦Côte d'Ivoire、苏丹Sudan、坦桑尼亚Tanzania (U.R)、埃塞尔比亚Ethiopia、赞比亚Zambia | 2 | 乌干达Uganda、莫桑比克Mozambique | 2 | 刚果金Congo (D.R)、尼日利亚Nigeria | 13 | 55.7 | ||
西部非洲WA | 2 | 几内亚比绍Guinea-Bissau、冈比亚Gambia | 6 | 几内亚Guinea、尼日尔Niger、马里Mali、塞拉利昂Sierra Leone、塞内加尔Senegal、利比里亚Liberia | 1 | 布基纳法索Burkina Faso | 0 | 0 | 9 | 12.5 | ||||
中部非洲CA | 5 | 多哥Togo、中非共和国Central African Republic、刚果(布)Congo、圣多美和普林西比Sao Tome and Principe、佛得角Cape Verde | 3 | 乍得Chad、布隆迪Burundi、贝宁Benin | 1 | 喀麦隆Cameroon | 0 | 0 | 9 | 7.8 | ||||
东南非洲SEA | 5 | 安哥拉Angola、科摩罗Comoros、斯威士兰Swaziland、纳米比亚Namibia、博茨瓦纳Botswana | 2 | 马达加斯加Madagascar、卢旺达Rwanda | 1 | 马拉维Malawi | 0 | 0 | 8 | 6.2 | ||||
中东北非MENA | 5 | 索马里Somalia、厄立特里亚Eritrea、中东响应项目Middle East Responseb、毛里塔尼亚Mauritania、吉布提Djibouti | 1 | 南苏丹South Sudan | 0 | 0 | 0 | 6 | 3.9 | |||||
高影响亚洲 HI Asia | 2 | 孟加拉Bangladesh、菲律宾Philippines | 2 | 印尼Indonesia、巴基斯坦Pakistan | 2 | 青蒿素抗性项目Regional Artemisinin Resistan ceInitiative (RAI) c、印度India | 0 | 0 | 6 | 9.9 | ||||
东南亚SE Asia | 9 | 阿富汗Afghanistan、巴布亚新几内亚Papua New Guinea、东帝汶Timor-Leste、朝鲜Korea (D.P.R)、所罗门群岛Solomon Islands、尼泊尔Nepal、斯里兰卡Sri Lanka、西太平洋地区项目Multi-country Western Pacificd、不丹Bhutan | 0 | 0 | 0 | 0 | 9 | 2.6 | ||||||
拉丁美洲和加勒比LAC | 7 | 海地Haiti、尼加拉瓜Nicaragua、危地马拉Guatemala、洪都拉斯Honduras、玻利维亚Bolivia、苏里南Suriname、圭亚那Guyana | 0 | 0 | 0 | 0 | 7 | 1.5 | ||||||
合计Total | 36 | 16 | 11 | 2 | 2 | 67 | 100 |
Table 3
Countries and application approaches for the Global Fund 2017-2019 malaria allocation
全球基金分区Global Fund Region | 滚动申请 Program continuation | 全新申请 Full review | 定制申请-重大变更Tailored-Material change | 定制申请-挑战性运营环境Tailored- Challenging operating environments | 定制申请-过渡申请Tailored-Transition | 定制申请-国家策略试点Tailored- National strategy-based pilots | 小计Subtotal |
---|---|---|---|---|---|---|---|
高影响非洲HI Africa | 5 | 7 | 1 | 0 | 0 | 0 | 13 |
西部非洲WA | 8 | 0 | 0 | 1a | 0 | 0 | 9 |
中部非洲CA | 6 | 2 | 1 | 0 | 0 | 0 | 9 |
东南非洲SEA | 3 | 1 | 2 | 0 | 1b | 1c | 8 |
中东北非MENA | 2 | 0 | 2 | 2d | 0 | 0 | 6 |
高影响亚洲HI Asia | 3 | 3 | 0 | 0 | 0 | 0 | 6 |
东南亚SE Asia | 4 | 1 | 3 | 0 | 1e | 0 | 9 |
拉丁美洲和加勒比LAC | 6 | 1 | 0 | 0 | 0 | 0 | 7 |
合计Total | 37 | 15 | 9 | 3 | 2 | 1 | 67 |
Table 4
Application status to the Global Fund 2017-2019 malaria allocation
全球基金分区 Global Fund Region | 项目批准委员会批准Final Grant Approval Committee meeting | 立项阶段 Grant-making | 修改后评审 Revised review | 重新提交 Iteration | 尚未提交a Yet submitteda | 小计 Subtotal |
---|---|---|---|---|---|---|
高影响非洲HI Africa | 1 | 12 | 0 | 0 | 0 | 13 |
西部非洲WA | 0 | 8 | 0 | 0 | 1b | 9 |
中部非洲CA | 0 | 9 | 0 | 0 | 0 | 9 |
东南非洲SEA | 0 | 2 | 1c | 2d | 3e | 8 |
中东北非MENA | 0 | 3 | 0 | 0 | 3f | 6 |
高影响亚洲HI Asia | 2 | 4 | 0 | 0 | 0 | 6 |
东南亚SE Asia | 1 | 5 | 0 | 0 | 3g | 9 |
拉丁美洲和加勒比LAC | 0 | 3 | 0 | 0 | 4h | 7 |
合计Total | 4 | 46 | 1 | 2 | 14 | 67 |
[1] | World Health Organization. Global technical strategy for malaria 2016-2030[EB/OL].Geneva: World Health Organization, 2015(2016-01-22)[2017-08-31].. |
[2] | World Health Organization.World Malaria Report 2017 [EB/OL].Geneva: World Health Organization, 2017[2017-12-07]. . |
[3] | The Global Fund.Grant Overview [EB/OL].Geneva: The Global Fund [2017-8-31] . |
[4] | The Global Fund. The Global Fund Strategy 2017-2022, Investing to End Epidemics [EB/OL] . Geneva: The Global Fund, 2016[2017-8-31] . |
[5] | The Global Fund.Global Fund Notifies Countries on 2017-2019 Allocations [EB/OL].Geneva: The Global Fund, 2016 [2017-8-31] . |
[6] | The Global Fund. An updated list of all pledges and contributions [EB/OL].Geneva: The Global Fund, 2016[2017-8-31]. |
[7] | 央视网.“一带一路”卫生合作暨“健康丝绸之路”北京公报发布[EB/OL].北京: 央视网, 2017[2017-8-31]. . |
[8] | Lai S, Li Z, Wardrop NA, et al. Malaria in China, 2011-2015: an observational study[J].Bull World Health Organ, 2017, 95(8): 564-573. |
[9] | 中英全球卫生支持项目管理办公室(国家卫生计生委项目资金监管服务中心). 政策简报第29期:中国境外输入性疟疾应对策略[EB/OL].北京: 中英全球卫生支持项目管理办公室(国家卫生计生委项目资金监管服务中心), 2017[2017-9-3] . . |
[10] | Zhang J, Dong JQ, Li JY, et al. Effectiveness and impact of the cross-border healthcare model as implemented by non-governmental organizations: case study of the malaria control programs by health poverty action on the China-Myanmar border[J]. Infect Dis Poverty, 2016, 5(1): 80. |
[11] | 张丽, 周水森, 丰俊, 等. 2014年全国疟疾疫情分析[J].中国寄生虫学与寄生虫病杂志, 2015, 33(5): 319-326. |
[12] | The Global Fund. Global Fund Allocations for 2017-2019 Allocation Period [EB/OL] . Geneva: The Global Fund, 2016[2017-8-31] . |
[13] | The Global Fund. Funding Request Status Tracker [EB/OL].Geneva: The Global Fund, 2017[2017-8-31] . |
[14] | Xia ZG, Wang RB, Wang DQ, et al. China-Africa cooperation initiatives in malaria control and elimination[J].Adv Parasitol, 2014, 86: 319-337. |
[15] | 国家卫生计生委国际合作司. 大湄公河次区域跨境传染病联防联控项目联合指导委员会会议暨2015年度总结会[EB/OL].北京: 国家卫生计生委国际合作司, 2016[2017-9-3] . . |
[16] | 国家商务部国际经贸关系司. 中-澳-巴新签署疟疾控制三方发展合作试点项目协议[EB/OL].北京: 国家商务部国际经贸关系司, 2015[2017-9-3].. |
[17] | 国家卫生计生委国际合作司. 中国-澳大利亚-巴布亚新几内亚开启三方疟疾防控合作[EB/OL] . 北京: 国家卫生计生委国际合作司, 2016[2017-9-3] . . |
[18] | 中英全球卫生支持项目管理办公室(国家卫生计生委项目资金监管服务中心). GHSP“中英坦疟疾控制试点项目”中期调研工作顺利开展[EB/OL].北京: 中英全球卫生支持项目管理办公室(国家卫生计生委项目资金监管服务中心), 2017[2017-9-3] . . |
[19] | The Global Fund.2017-2019 Allocations Frequently Asked Questions [EB/OL] . Geneva: The Global Fund, 2016[2017-8-31] . |
[20] | The Global Fund.Funding Model [EB/OL] . Geneva: The Global Fund.[2017-9-3] . |
[21] | The Global Fund.Applying for funding [EB/OL].Geneva: The Global Fund.[2017-9-3] . |
[22] | World Health Organization.Prequalified Lists of finished phar-maceutical products [EB/OL].Geneva: World Health Organization.[2017-9-3]. |
[23] | 中英全球卫生支持项目管理办公室(国家卫生计生委项目资金监管服务中心). 政策简报第33期:中国抗疟药物研发现状与启示[EB/OL].北京: 中英全球卫生支持项目管理办公室(国家卫生计生委项目资金监管服务中心), 2017[2017-9-3].. |
[24] | 张庆锋, 王汝波, 郑彬, 等. 2003-2013年中国全球基金疟疾项目实施效果分析[J].中华预防医学杂志, 2017, 51(5): 427-431. |
[25] | Wang RB, Zhang QF, Zheng B, et al. Transition from control to elimination: impact of the 10-year global fund project on malaria control and elimination in China[J].Adv Parasitol, 2014, 86: 289-318. |
[26] | 中英全球卫生支持项目管理办公室(国家卫生计生委项目资金监管服务中心). 政策简报第30期: 两个国际对华大型卫生援助项目的分析[EB/OL].北京: 中英全球卫生支持项目管理办公室(国家卫生计生委项目资金监管服务中心), 2017[2017-9-3].. |
[27] | 中英全球卫生支持项目管理办公室(国家卫生计生委项目资金监管服务中心). 政策简报第19期: 中国对非卫生发展合作与热带病[EB/OL].北京: 中英全球卫生支持项目管理办公室(国家卫生计生委项目资金监管服务中心), 2017[2017-9-3].. |
[28] | 王云屏, 金楠, 樊晓丹. 中国对外援助医疗卫生机构的历史、现状与发展趋势[J].中国卫生政策研究, 2017, 10(8): 60-67. |
[29] | 王云屏, 梁文杰, 杨洪伟, 等. 中国卫生发展援助的理念与实践[J].中国卫生政策研究, 2015, 8(5): 37-43. |
[30] | The Global Fund.Global Fund Overview [EB/OL].Geneva: The Global Fund[2017-9-3]. |
[31] | David Garmaise. NEWS and ANALYSIS: The Global Fund’s business model: evolution, not revolution [EB/OL].Geneva: the Global Fund Observer, 2017[2017-9-5].. |
[32] | Sachs JD, Schmidt-Traub G.Global Fund lessons for Sustainable Development Goals[J].Science, 2017, 356(6333): 32-33. |
[1] | WANG Rong, XU Jie, ZHU Xiaotong. Research advances on transmission-blocking vaccines targeting Plasmodium sexual stage [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024, 42(3): 399-406. |
[2] | YANG Hexian, HUANG Dongsheng, NIE Fangang. Analysis on malaria epidemic and control measures in Baoshan City of Yunnan Province in 2023 [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024, 42(3): 418-420. |
[3] | ZHANG Li, XIA Zhigui. Epidemiological characteristics of malaria in China, 2023 [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024, 42(2): 135-139. |
[4] | XU Yan, WANG Longjiang, KONG Xiangli, LI Yuejin, BU Cancan, YAN Ge, ZHANG Benguang, WANG Yongbin. Epidemiological characteristics of imported malaria in Shandong Province in 2017—2022 [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024, 42(2): 140-146. |
[5] | WEN Jing, GUO Mingquan, ZHANG Bei, ZHANG Tengfei, PAN Shuai, SUN Danfeng, QI Weiqiang. Epidemiological analysis of imported malaria in Shanghai Public Health Clinical Center from 2012 to 2022 [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024, 42(2): 147-152. |
[6] | YAN He, HUANG Fang, FENG Jun, YIN Jianhai, XIA Zhigui, CAO Jianping. Polymorphism of sulfadoxine-pyrimethemine resistant gene of Plasmodium falciparum in China-Myanmar border area from 2010 to 2018 [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024, 42(2): 153-159. |
[7] | TONG Guodong, ZHU Qinghao, WANG Jun, LIU Xiaoran, SHEN Yan, LIANG Jiao, LI Yinghui, HUANG Yuxiao, WANG Yi, ZHAO Ya. Activation of astrocytes and neuronal damage induced by the inflammatory microenvironment of cerebral malaria [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024, 42(2): 160-168. |
[8] | YI Jia, WU Dongni, DONG Xiaorong, ZHU Hong, LIN Wen, ZHANG Cong, SUN Lingcong. Analysis of laboratory detection capability for imported malaria in Hubei Province before and after malaria elimination [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024, 42(2): 177-181. |
[9] | HE Yisha, XIE Chaoyong, WANG Yu, LI Yanjing. The analysis of the epidemiological characteristics and the diagnosis of imported malaria before and after the COVID-19 pandemic in Nanjing City [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024, 42(2): 267-271. |
[10] | KUI Yan, XUE Chuizhao, WANG Xu, LIU Baixue, WANG Ying, WANG Liying, YANG Shijie, HAN Shuai, XU Xuenian. Progress of echinococcosis control in China, 2022 [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024, 42(1): 8-16. |
[11] | ZHU Min, ZHANG Hao, WU Liming, ZHANG Chengang, ZHANG Yaoguang, WANG Zhenyu, CHEN Jian, WU Huanyu, CHEN Xin. Analysis on implementation and effectiveness of imported malaria surveillance-response system post-elimination in Shanghai [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024, 42(1): 91-97. |
[12] | ZOU Wenjian, WU Linbo, XU Xiang, TANG Yerong, SUN Xiaodong, ZENG Xucan. Investigation on host-feeding habits of Anopheles minimus in Yingjiang County at the China-Myanmar border [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024, 42(1): 125-128. |
[13] | LI Chunyan, ZHANG Fuyan, SHI Peng, TIAN Fengyuan. Analysis of imported malaria epidemic in Zigong City of Sichuan Province from 2011 to 2023 [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024, 42(1): 129-133. |
[14] | LI Yuanyuan, ZHOU Zhengbin, YANG Limin, LI Zhongqiu, LIU Qin, ZHANG Yi, LI Shizhu. Epidemiological characteristics of visceral leishmaniasis in China in 2022 [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2023, 41(6): 669-676. |
[15] | YANG Shuo, XIA Shang, YAN Shuning, XUE Jingbo, SHI Benyun, HAO Yuwan, LI Mengru, LIANG Jiarui, XIA Zhigui, ZHENG Bin. Analysis on the sources of imported malaria risk in China based on international trade relations [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2023, 41(6): 744-748. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||